Clinical Trials
22 trialsA Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
CMR-Onko
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
STOP-MED CTRCD
University Health Network, Toronto
BREATHS
University College, London
BE-FITTER
University of Alberta
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
HIMALAYAS
University Health Network, Toronto
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
TRUST-ACE
Norwegian University of Science and Technology
HER2BIC
Odense University Hospital
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Texas Tech University Health Sciences Center
Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML
Samara State Medical University
PROTECT-COR
Erasmus Medical Center
NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity
Vastra Gotaland Region
LYMfit
Norwegian School of Sport Sciences
START
Zhejiang Cancer Hospital
NARNIA
University Hospital, Akershus
PROTHYM
Swedish Lung Cancer Study Group